Pallanti S, Grassi G, Sarrecchia ED, Cantisani A, Pellegrini M
GLP-1 receptor agoniststhe class of drugs that includes semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)are synthetic molecules engineered to mimic and amplify this exact hormonal signal
[2] [3] Additional important safety considerations include risk of pancreatitis (discontinue if suspected), gallbladder disease, acute kidney injury from dehydration during severe gastrointestinal adverse events, and potential diabetic retinopathy complications in patients with a history of retinopathy
Lunde PK, Sjaastad I, Schiotz Thorud HM, Sejersted OM
These are as follows: Size of the syringe